1008-17: The Management of Mood and Anxiety Disorders in Pregnancy and Postpartum

The purpose of this session is to provide evidence-based discussion of the management of mood and anxiety disorders in pregnancy and postpartum.

Presenter: Lauren M. Osborne, MD

Disclosures: Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will occur in this presentation.

Session Length: 1 hour 26 minutes

Target Audience: RN, APRN 

Session Objectives:
Upon completion of this presentation, the participant will be able to:

1. Define the potential risks and benefits of psychiatric medication in pregnancy.
2. Define the potential risks of no treatment for psychiatric illness during and after pregnancy.
3. Identify 2 or more treatment alternatives to psychiatric medication during and after pregnancy.

Keywords: Practice, Mood Disorders, Pregnancy, Pharmacology

Continuing Nursing Education
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, earn a passing score on the post test and complete an evaluation before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 15th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Saturday, June 10, 2017
9:45am – 11:15am

The contact hours for this session expire: July 1, 2020